Growth hormone receptor promotes osteosarcoma cell growth and metastases

FEBS Open Bio. 2020 Jan;10(1):127-134. doi: 10.1002/2211-5463.12761. Epub 2019 Dec 18.

Abstract

Osteosarcoma (OS) is the primary bone malignancy in children and adolescents, with a high incidence of lung metastasis and poor prognosis. Here, we report that growth hormone receptor (GHR) is overexpressed in OS samples compared with osteofibrous dysplasia. We subsequently demonstrated that GHR knockdown inhibited colony formation, promoted cell apoptosis and decreased the number of cells at G2/M phase in 143B and U2OS cells. Furthermore, knockdown of GHR inhibited tumor growth in vivo. Together, these findings indicate that GHR modulates cell proliferation and metastasis through the phosphoinositide 3-kinase/AKT signaling pathway and may be suitable for use as a putative biomarker of OS.

Keywords: growth hormone receptor; metastasis; osteosarcoma; proliferation; tumor growth.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Bone Diseases, Developmental / drug therapy
  • Bone Diseases, Developmental / metabolism*
  • Bone Diseases, Developmental / pathology
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / metabolism*
  • Bone Neoplasms / pathology
  • Cell Proliferation / drug effects
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / metabolism
  • Neoplasms, Experimental / pathology
  • Osteosarcoma / drug therapy
  • Osteosarcoma / metabolism*
  • Osteosarcoma / pathology
  • RNA, Small Interfering / pharmacology
  • Receptors, Somatotropin / antagonists & inhibitors
  • Receptors, Somatotropin / genetics
  • Receptors, Somatotropin / metabolism*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • RNA, Small Interfering
  • Receptors, Somatotropin

Supplementary concepts

  • Osteofibrous Dysplasia